Masaya Akai
Overview
Explore the profile of Masaya Akai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakashima K, Umeda Y, Demura Y, Takeda T, Tada T, Sato M, et al.
BMC Pulm Med
. 2023 Jun;
23(1):206.
PMID: 37316839
Background: Although transbronchial diagnostic procedures are sometimes difficult to perform because of the patient's respiratory or general conditions, endoscopic ultrasound with bronchoscope-guided fine-needle aspiration (EUS-B-FNA), a known transesophageal diagnostic procedure,...
2.
Sonoda T, Umeda Y, Demura Y, Tada T, Nakashima K, Anzai M, et al.
Cancer Med
. 2023 Apr;
12(12):13041-13053.
PMID: 37081729
Background: Whether immunotherapy improves the efficacy or worsens adverse events of subsequent chemotherapy remains unclear. We performed a Phase 2 study to evaluate the efficacy and safety of nanoparticle albumin-bound...
3.
Nakashima K, Demura Y, Tada T, Akai M, Ishizuka T
Ann Palliat Med
. 2022 Dec;
12(1):188-192.
PMID: 36510458
Background: A disease progression pattern in a limited number of sites, called oligoprogression, is relatively common in patients with lung cancer during immunotherapy. It is controversial how to manage clinically...
4.
Nakashima K, Demura Y, Kurokawa K, Takeda T, Jikuya N, Oi M, et al.
Case Reports Immunol
. 2022 Jan;
2022:9290922.
PMID: 35036012
Paraneoplastic neurological syndrome (PNS) is associated with malignancies, including small-cell lung cancer. Recently, PNS cases among patients with small-cell lung cancer (SCLC) induced by immune checkpoint inhibitors have increased. We...
5.
Nakashima K, Demura Y, Tada T, Akai M, Ishizuka T
J Bronchology Interv Pulmonol
. 2021 Dec;
29(2):155-157.
PMID: 34907976
No abstract available.
6.
Nakashima K, Demura Y, Kurokawa K, Takeda T, Jikuya N, Oi M, et al.
Medicine (Baltimore)
. 2021 Oct;
100(39):e27385.
PMID: 34596160
Rationale: Although anaplastic lymphoma kinase (ALK) inhibitors are effective treatment options for ALK-positive non-small cell lung cancer (NSCLC) with central nervous system (CNS) metastasis, achieving long-term survival in patients with...
7.
Nakashima K, Demura Y, Akai M, Ishizuka T
Cureus
. 2021 Aug;
13(7):e16177.
PMID: 34367784
Immune checkpoint inhibitors may cause specific immune-related reactions, such as pseudo-progression. In particular, malignant pleural effusion tends to worsen due to this phenomenon. However, the appropriate management in such cases...
8.
Oi I, Ito I, Hirabayashi M, Endo K, Emura M, Kojima T, et al.
Open Forum Infect Dis
. 2021 Jul;
8(7):ofab282.
PMID: 34291119
Background: Detailed differences in clinical information between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia (CP), which is the main phenotype of SARS-CoV-2 disease, and influenza pneumonia (IP) are still...
9.
Nakashima K, Demura Y, Oi M, Tabata M, Tada T, Shiozaki K, et al.
Intern Med
. 2020 Nov;
60(7):1061-1065.
PMID: 33132332
Since it is difficult to obtain tumor tissue via airway observation for lung cancer patients with a poor respiratory condition, endoscopic ultrasound with bronchoscope-guided fine-needle-aspiration (EUS-B-FNA), a transesophageal procedure, is...
10.
Nakashima K, Demura Y, Oi M, Tabata M, Tada T, Shiozaki K, et al.
Intern Med
. 2020 Oct;
60(5):771-775.
PMID: 33055477
Malignant pleural mesothelioma (MPM) is mostly observed in patients with a history of asbestos exposure. Although other causes are rare, there are several reports of MPM induced by therapeutic radiation,...